In previous studies, the selective serotonin reuptake inhibitor fluvoxamine preferentially reduced responding for ethanol compared with responding for food under conditions in which each was available alone in separate groups or in the same subjects under a multiple schedule in which baseline response rates were matched. The impact of providing concurrent access to food on pharmacological effects on ethanol self-administration remains largely unexplored. In this study, acute doses of fluvoxamine (3.0-17.8 mg/kg) were administered 30-min before the experimental session to Lewis rats responding under a concurrent fixed-ratio, fixed-ratio schedule of ethanol and food presentation. Ratios for food were adjusted for each subject to provide matched rates of food and ethanol reinforcement across the 30-min session. Although the number of ethanol and food deliveries did not significantly differ under baseline conditions, response rates did differ. Following fluvoxamine administration, responding for food was decreased more than responding for ethanol. This differential effect did not appear to be related to response rate or fixed-ratio size. Thus, the selectivity of fluvoxamine on ethanol-versus food-maintained responding depends upon the context in which the behavior occurs. Such results may help explain inconsistencies between preclinical results and those in humans, and could provide insight into the behavioral determinants of pharmacological effects on ethanol self-administration.
Keywordsoperant; alcoholism; alcohol; SSRI; lever-press; Lewis rat; concurrent schedule; foodThe development of methods to study ethanol-maintained behavior has led to a greater understanding of the neurobiology of as well as a means for searching for potential treatments for alcoholism (Meisch and Henningfield, 1977;Samson, 1986). Methods of studying ethanol self-administration have been refined since the earliest reports (see Samson et al., 2000). Among these refinements is the incorporation of the concept of a therapeutic index. For example, a potential pharmacotherapy for alcoholism should reduce behavior maintained by ethanol, but not (or at least to a lesser extent) reduce behavior maintained by
Publisher's Disclaimer:The following manuscript is the final accepted manuscript. It has not been subjected to the final copyediting, fact-checking, and proofreading required for formal publication. It is not the definitive, publisher-authenticated version. The American Psychological Association and its Council of Editors disclaim any responsibility or liabilities for errors or omissions of this manuscript version, any version derived from this manuscript by NIH, or other third parties. The published version is available at www.apa.org/pubs/journals/PHA NIH Public Access
Author ManuscriptExp Clin Psychopharmacol. Author manuscript; available in PMC 2011 October 27.
NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA Author Manuscript other events. Further, more attention has been focused on controlling parameters known to be det...